Skip to main content

ROYAL LONDON ASSET MANAGEMENT LTD

Position in GILD — Gilead Sciences, Inc.

CIK 863748 UNITED KINGDOM, X0

Position in GILD

as of Mar 31, 2026 · filed May 1, 2026
Position Value
$79,626,680
+$11,857,385 QoQ
Shares Held
571,333
+3.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

ROYAL LONDON ASSET MANAGEMENT LTD holds $3,896,027,978 across 10 Drug Manufacturers - General names. GILD ranks #7 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 GILD
Gilead Sciences, Inc.
This page
571,333 $79,626,680

All Filings in GILD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $79,626,680 571,333
2025-12-31 $67,769,295 552,137
2025-09-30 $61,707,564 555,924
2025-06-30 $63,330,939 571,218
2025-03-31 $65,280,105 582,598
2024-12-31 $65,283,883 706,765
2024-09-30 $73,526,170 876,982
2024-06-30 $61,715,312 899,509
2024-03-31 $89,528,640 1,222,234
2023-12-31 $84,645,323 1,044,875
2023-09-30 $63,199,150 843,330
2023-06-30 $47,755,346 619,636
2023-03-31 $48,073,066 579,403
2022-12-31 $54,148,256 630,731
2022-09-30 $38,351,500 621,681
2022-06-30 $40,418,300 653,912
2022-03-31 $38,958,595 655,317
2021-12-31 $45,766,518 630,306
2021-09-30 $45,914,570 657,331
2021-06-30 $46,456,949 674,658
2021-03-31 $44,729,582 692,087
2020-12-31 $39,067,524 670,572
2020-09-30 $42,327,884 669,851
2020-06-30 $51,678,289 671,670
2020-03-31 $51,586,867 690,033